All News Valeo Pharma Inc.

Equities

VPH

CA91915B1085

Delayed Toronto S.E. Other stock markets 01:36:42 2024-04-29 pm EDT			5-day change	1st Jan Change
0.1 ^CAD	-13.04%		-9.09%	-44.44%

Apr. 25	Transcript : Valeo Pharma Inc. - Shareholder/Analyst Call
Mar. 22	Valeo Pharma Inc. Announces Appointment of Al Moghaddam to Board of Directors	CI

All News

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

VALEO PHARMA ANNOUNCES RESULTS OF ANNUAL MEETING OF SHAREHOLDERS	Apr. 25	AQ
Transcript : Valeo Pharma Inc. - Shareholder/Analyst Call	Apr. 25
VALEO PHARMA TO PRESENT AT THE 2024 BLOOM BURTON & CO HEALTHCARE INVESTOR CONFERENCE	Apr. 09	AQ
VALEO PHARMA ANNOUNCES APPOINTMENT OF MR. AL MOGHADDAM TO BOARD OF DIRECTORS	Mar. 25	AQ
VALEO PHARMA ANNOUNCES APPOINTMENT OF MR. AL MOGHADDAM TO BOARD OF DIRECTORS	Mar. 22	AQ
Valeo Pharma Inc. Announces Appointment of Al Moghaddam to Board of Directors	Mar. 22	CI
Transcript : Valeo Pharma Inc., Q1 2024 Earnings Call, Mar 15, 2024	Mar. 15
VALEO PHARMA REPORTS FIRST QUARTER 2024 RESULTS	Mar. 14	AQ
Valeo Pharma Inc. Reports Earnings Results for the First Quarter Ended January 31, 2024	Mar. 14	CI
VALEO PHARMA TO HOST FIRST QUARTER 2024 RESULTS CONFERENCE CALL, WEBCAST	Mar. 08	AQ
VALEO PHARMA TO HOST FIRST QUARTER 2024 RESULTS CONFERENCE CALL / WEBCAST	Mar. 07	AQ
VALEO PHARMA ANNOUNCES BOARD OF DIRECTORS CHANGES	Feb. 13	AQ
Valeo Pharma Inc. Announces Board Changes	Feb. 13	CI
Valeo Pharma Brief: Notes Sagard credit facility amended to provide for early repayments and liquidity requirements in fiscal 2024	Feb. 02	MT
Valeo Pharma Brief: Says Proceeds from reimbursement to be used for debt reduction purposes	Feb. 02	MT
Valeo Pharma Brief: Adding SIMBRINZA remains under Valeo Pharma exclusive promotion and distribution	Feb. 02	MT
Valeo Pharma Brief: Says Original commercialization and supply agreement amended following global divestment of XIIDRA	Feb. 02	MT
Valeo Pharma Brief: Amending Agreement With Novartis Pharmaceuticals Canada For XIIDRA In Canada, and Credit Facility With Sagard Healthcare Royalty Partners, LP	Feb. 02	MT
VALEO PHARMA AMENDS AGREEMENT WITH NOVARTIS PHARMACEUTICALS CANADA FOR (Pr)XIIDRA® IN CANADA AND CREDIT FACILITY WITH SAGARD HEALTHCARE ROYALTY PARTNERS, LP	Feb. 02	AQ
Valeo Pharma Amends Agreement with Novartis Pharmaceuticals Canada for (Pr)XIIDRA in Canada	Feb. 02	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

All News Valeo Pharma Inc.

Equities

VPH

CA91915B1085

All News

Filters